
Sign up to save your podcasts
Or


Michael Cloonan, CEO of Sionna Therapeutics, shares his insights about leadership in biopharma and how Sionna is working to restore the cystic fibrosis transmembrane conductance regulator for people living with cystic fibrosis.
By John Simboli5
77 ratings
Michael Cloonan, CEO of Sionna Therapeutics, shares his insights about leadership in biopharma and how Sionna is working to restore the cystic fibrosis transmembrane conductance regulator for people living with cystic fibrosis.

535 Listeners

3,079 Listeners

1,094 Listeners

938 Listeners

796 Listeners

124 Listeners

324 Listeners

92 Listeners

9,953 Listeners

33 Listeners

498 Listeners

147 Listeners

353 Listeners

171 Listeners

512 Listeners